Trademark: 87232887
Word
ZYGENSIS
Status
Registered
Status Code
700
Status Date
Tuesday, March 26, 2019
Serial Number
87232887
Registration Number
5706585
Registration Date
Tuesday, March 26, 2019
Mark Type
4000
Filing Date
Thursday, November 10, 2016
Published for Opposition
Tuesday, November 7, 2017

Trademark Owner History
SANDOZ AG -
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Mar 26, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 6, 2023
Automatic Update Of Assignment Of Ownership
Mar 26, 2019
Registered-Principal Register
Feb 20, 2019
1(B) Basis Deleted; Proceed To Registration
Jan 18, 2019
Notice Of Allowance Cancelled
Feb 20, 2019
Case Assigned To Intent To Use Paralegal
Jan 18, 2019
Teas Delete 1(B) Basis Received
Jan 11, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2019
Sou Extension 1 Granted
Jan 9, 2019
Sou Extension 1 Filed
Jan 9, 2019
Sou Teas Extension Received
Jul 10, 2018
Noa E-Mailed - Sou Required From Applicant
May 29, 2018
Changes/Corrections After Pub Approval Entered
May 23, 2018
Assigned To Petition Staff
May 17, 2018
Extension Of Time To Oppose Process - Terminated
May 3, 2018
Teas Post Publication Amendment Received
Dec 7, 2017
Extension Of Time To Oppose Received
Nov 7, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2017
Published For Opposition
Oct 18, 2017
Notification Of Notice Of Publication E-Mailed
Oct 3, 2017
Law Office Publication Review Completed
Oct 2, 2017
Approved For Pub - Principal Register
Oct 2, 2017
Teas/Email Correspondence Entered
Oct 2, 2017
Correspondence Received In Law Office
Sep 24, 2017
Teas Response To Office Action Received
Sep 12, 2017
Notification Of Non-Final Action E-Mailed
Sep 12, 2017
Non-Final Action E-Mailed
Sep 12, 2017
Non-Final Action Written
Sep 5, 2017
Teas/Email Correspondence Entered
Sep 5, 2017
Correspondence Received In Law Office
Aug 31, 2017
Assigned To Lie
Aug 15, 2017
Teas Response To Office Action Received
Feb 16, 2017
Notification Of Non-Final Action E-Mailed
Feb 16, 2017
Non-Final Action E-Mailed
Feb 16, 2017
Non-Final Action Written
Feb 16, 2017
Assigned To Examiner
Nov 16, 2016
New Application Office Supplied Data Entered
Nov 14, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24